TrueDx TSH assay is an acceptable screening test for both hypo- and hyperthyroidism in the general population: correlation between trueDx TSH assay and the standard 3rd Generation TSH Chemoluminiscence Immunoassay (CMIA)

Shahar, Mohammad Arif and Omar, Ahmad Marzuki and Ab Wahab, Norasyikin and Sukor, Norlela and Kamaruddin, Nor Azmi (2017) TrueDx TSH assay is an acceptable screening test for both hypo- and hyperthyroidism in the general population: correlation between trueDx TSH assay and the standard 3rd Generation TSH Chemoluminiscence Immunoassay (CMIA). International Journal of Thyroidology, 10 (Suppl. 1). S178. ISSN 2384-3799 E-ISSN 2466-1899

PDF - Published Version Restricted to Registered users only Download (4MB) | Request a copy

Abstract

To determine the correlation between the TrueDx TSH assay and the standard 3rd generation chemoluminescence microparticle immunoassay (CMIA) This is a cross sectional study involving 212 healthy volunteers who participated in a hypothyroidism awareness campaigns carried out at several shopping malls in Kuala Lumpur, Malaysia. Upon obtaining an informed consent, sociodemographic characteristics and full medical history were documented, followed by a complete physical examination. Capillary blood was obtained for the TrueDx TSH assay while venous blood was withdrawn and sent to a centralized chemical pathology laboratory for TSH testing using the 3rd generation TSH CMIA (Architect system). The TSH TrueDx test machine was provided by Merck Malaysia. The mean age of the subjects was 45.2 ± 13.9 years. Majority of volunteers were females (68.4%). The ethnic distribution was 66.0% Chinese, 27.8% Malays and 5.7% Indians. The median levels for TSH measured by TrueDx assay and TSH CMIA were 1.79(1.32,2.61) and 1.08(0.70,1.48)uIU/mL respectively. The TrueDx TSH assay has a modest correlation with the 3rd generation TSH CMIA (Spearman's rho = 0.66, p < 0.001). The positive predictive value (PPV) and negative predictive value (NPV) for TrueDx assay in detecting hypothyroidism were 0.20 and 1.00 respectively, with the sensitivity and specificity of 100% and 96%. While the PPV and NPV for TrueDx assay in detecting hyperthyroidism was 0.50 and 0.98, respectively with the sensitivity and specificity of 63% and 97%. TrueDx TSH assay is too sensitive in diagnosing hypo- and hyperthyroidism on it's own (PPV 20% for hypothyroidism, PPV 50% for hyperthyroidism) but with the very high specificities and NPVs for both hypo- and hyperthyroidism it serves as a satisfactory screening test for thyroid disorders. However, subjects who returned with TSH levels suggestive of either hypo- or hyperthyroidism with TrueDx must have a confirmatory test with the 3rd generation CMIA TSH test.

Item Type:	Article (Journal)
Additional Information:	5471/58586
Uncontrolled Keywords:	TrueDx TSH, both hypo-and hyperthyroidism, corelation, trueDx TSH assay, standard 3rd
Subjects:	R Medicine > R Medicine (General) R Medicine > RC Internal medicine
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Medicine > Department of Internal Medicine
Depositing User:	Dr Mohammad Arif Shahar
Date Deposited:	02 Oct 2017 10:58
Last Modified:	12 Jan 2018 19:14
URI:	http://irep.iium.edu.my/id/eprint/58586

Actions (login required)

View Item